# A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)

> **NCT06842121** · PHASE1 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 42 (actual)

## Conditions studied

- Parenteral Nutrition

## Interventions

- **DRUG:** Sodium Glycerophosphate Injection
- **DRUG:** Sodium Phosphates Injection

## Key facts

- **NCT ID:** NCT06842121
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-27
- **Primary completion:** 2025-05-22
- **Final completion:** 2025-05-22
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06842121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06842121, "A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06842121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*